Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa

Journal of Infectious Diseases

Volumn 207, Issue 1, 2013, Pages 9-17

  Gandhi, Neel R ^a,b   Weissman, Darren ^a   Moodley, Prashini ^c   Ramathal, Melissa ^c   Elson, Inga ^c   Kreiswirth, Barry N ^d   Mathema, Barun ^d   Shashkina, Elena ^d   Rothenberg, Richard ^e   Moll, Anthony P ^f   Friedland, Gerald ^g   Sturm, A Willem ^c   Shah, N Sarita ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^e GEORGIA STATE UNIVERSITY   (United States)

^f Philanjalo and Church of Scotland Hospital   (South Africa)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug resistance; Genotyping; HIV; Transmission; Tuberculosis

Indexed keywords

ADULT; ARTICLE; BACTERIUM ISOLATE; DISEASE TRANSMISSION; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GENE CLUSTER; GENOTYPE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIAL NETWORK; SOUTH AFRICA;

ADULT; ANTITUBERCULAR AGENTS; CLUSTER ANALYSIS; CROSS INFECTION; DRUG THERAPY, COMBINATION; ETHAMBUTOL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; GENOTYPE; HIV INFECTIONS; HOSPITALS, RURAL; HUMANS; ISONIAZID; MALE; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; PYRAZINAMIDE; RETROSPECTIVE STUDIES; RIFAMPIN; SEQUENCE ANALYSIS, DNA; SOUTH AFRICA;

EID: 84872947665     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis631     Document Type: Article

References (51)

1. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep 1991; 40:585-91.
2. Frieden TR, Sherman LF, Maw KL, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 1996; 276:1229-35.
3. Rullan JV, Herrera D, Cano R, et al. Nosocomial transmission of multidrug- resistant Mycobacterium tuberculosis in Spain. Emerg Infect Dis 1996; 2:125-9.
4. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrugresistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326:1514-21.
5. Moro ML, Gori A, Errante I, et al. An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. Italian Multidrug-Resistant Tuberculosis Outbreak Study Group. AIDS 1998; 12:1095-102.
6. Wells CD, Cegielski JP, Nelson LJ, et al. HIV infection and multidrug- resistant tuberculosis: the perfect storm. J Infect Dis 2007; 196(Suppl 1):S86-107.
7. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med 1995; 333:229-33.
8. Wenger PN, Otten J, Breeden A, Orfas D, Beck-Sague CM, Jarvis WR. Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients. Lancet 1995; 345:235-40.
9. Maloney SA, Pearson ML, Gordon MT, Del CR, Boyle JF, Jarvis WR. Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med 1995; 122:90-5.
10. World Health Organization. Multidrug-resistant and extensively drugresistant tuberculosis: 2010 global report on surveillance and response. Geneva, Switzerland: World Health Organization, 2010. Report no. WHO/HTM/tuberculosis/2010.3.
11. Ritacco V, Di Lonardo M, Reniero A, et al. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis 1997; 176:637-42.
12. Sacks LV, Pendle S, Orlovic D, Blumberg L, Constantinou C. A comparison of outbreak- and nonoutbreak-related multidrug-resistant tuberculosis among human immunodeficiency virus-infected patients in a South African hospital. Clin Infect Dis 1999; 29:96-101.
13. Campos PE, Suarez PG, Sanchez J, et al. Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Emerg Infect Dis 2003; 9:1571-8.
14. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368:1575-80.
15. Oeltmann JE, Varma JK, Ortega L, et al. Multidrug-resistant tuberculosis outbreak among US-bound Hmong refugees, Thailand, 2005. Emerg Infect Dis 2008; 14:1715-21.
16. Tuberculosis MDR/XDR: The Msinga experience 2005-2009. http://www.kznhealth.gov.za/tuberculosismsinga.pdf. Accessed 7 July 2011.
17. Gandhi NR, Shah NS, Andrews JR, et al. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med 2010; 181:80-6.
18. Shisana O, Rehle T, Simbayi LC, et al. South African national HIV prevalence, incidence, behavior and communication survey 2008: a turning tide among teenagers? Cape Town: HSRC Press, 2009.
19. The South African National Tuberculosis Control Programme Practical Guidelines. http://www.kznhealth.gov.za/chrp/documents/Guidelines/ Guidelines%20National/Tuberculosis/SA%20tuberculosis%20Guidelines %202004.pdf. Accessed 19 December 2011.
20. Wallengren K, Scano F, Nunn P, et al. Drug-resistant tuberculosis, KwaZulu-Natal, South Africa, 2001-2007. Emerg Infect Dis 2011; 17:1913-6.
21. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragmentlength polymorphisms. N Engl J Med 1992; 326:231-5.
22. DiPerri G, Cruciani M, Danzi MC, et al. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 1989; 2:1502-4.
23. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35:907-14.
24. Brudey K, Driscoll JR, Rigouts L, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006; 6:23.
25. van Embden JD, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31:406-9.
26. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998; 79:3-29.
27. Maus CE, Plikaytis BB, Shinnick TM. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005; 49:3192-7.
28. Spies FS, Ribeiro AW, Ramos DF, et al. Streptomycin resistance and lineage-specific polymorphisms in Mycobacterium tuberculosis gidB gene. J Clin Microbiol 2011; 49:2625-30.
29. Gandhi N, Shenoi S, Shah N, et al. Low genetic diversity among MDR & XDR tuberculosis isolates from Tugela Ferry, South Africa, 2005- 2006. Presented at: 2009 American Thoracic Society International Conference, San Diego, California, May 2009.
30. Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E. Genotypic diversity of extensively drug-resistant tuberculosis (XDRtuberculosis) in South Africa. Int J Tuberc Lung Dis 2008; 12:99-104.
31. Dheda K, Shean K, Zumla A, et al. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet 2010; 375:1798-807.
32. Escombe AR, Oeser CC, Gilman RH, et al. Natural ventilation for the prevention of airborne contagion. PLoS Med 2007; 4:e68.
33. Escombe AR, Moore DA, Gilman RH, et al. The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med 2008; 5:e188.
34. Pillay M, Sturm AW. Evolution of the extensively drug-resistant F15/ LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clin Infect Dis 2007; 45:409-14.
35. Moodley P, Shah NS, Tayob N, et al. Spread of extensively drugresistant tuberculosis in KwaZulu-Natal province, South Africa. PLoS One 2011; 6:e17513.
36. Ioerger TR, Koo S, No EG, et al. Genome analysis of multi- and extensively- drug-resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS One 2009; 4:e7778.
37. McElroy PD, Sterling TR, Driver CR, et al. Use of DNA fingerprinting to investigate a multiyear, multistate tuberculosis outbreak. Emerg Infect Dis 2002; 8:1252-6.
38. Bifani PJ, Plikaytis BB, Kapur V, et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996; 275:452-7.
39. Keshavjee S, Gelmanova IY, Farmer PE, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 2008; 372:1403-9.
40. Sotgiu G, Ferrara G, Matteelli A, et al. Epidemiology and clinical management of XDR-tuberculosis: a systematic review by tuberculosisNET. Eur Respir J 2009; 33:871-81.
41. Bock NN, Jensen PA, Miller B, Nardell E. Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment. J Infect Dis 2007; 196(Suppl 1):S108-13.
42. World Health Organization. WHO Policy on tuberculosis Infection Control in Health-Care Facilities, Congregate Settings and Households. Geneva, Switzerland: World Health Organization, 2009. Report no. WHO/HTM/tuberculosis/ 2009.419.
43. Moore DA, Evans CA, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of tuberculosis. N Engl J Med 2006; 355:1539-50.
44. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363:1005-15.
45. Nathanson E, Nunn P, Uplekar M, et al. MDR tuberculosis - critical steps for prevention and control. N Engl J Med 2010; 363:1050-8.
46. Dheda K, Migliori GB. The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue? Lancet. 2011; 375:1798-1807.
47. Victor TC, Streicher EM, Kewley C, et al. Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. Int J Tuberc Lung Dis 2007; 11:195-201.
48. Zhao M, Li X, Xu P, et al. Transmission of MDR and XDR tuberculosis in Shanghai, China. PLoS One 2009; 4:e4370.
49. Calver AD, Falmer AA, Murray M, et al. Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerg Infect Dis 2010; 16:264-71.
50. Nardell E, Dharmadhikari A. Turning off the spigot: reducing drugresistant tuberculosis transmission in resource-limited settings. Int J Tuberc Lung Dis 2010; 14:1233-43.
51. Decrease in reported tuberculosis cases - United States, 2009. MMWR Morb Mortal Wkly Rep 2010; 59:289-94.